Poland· PL-100385698
Glurenorm
A gliquidone product containing gliquidonum, registered in Poland by InPharm Sp. z o.o.. The same ATC class is registered in 6 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Gliquidone is registered in 6 of 19 countries.
Countries holding a registration under ATC A10BB08 (gliquidone), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 4 of them publish a price we can compare per daily dose
Gliquidone · ATC A10BB08
6 / 19 countries
- Belgiumprice
- Czechiaprice
- Germany
- Italyprice
- Polandprice
- United Kingdom
Price per daily dose
What a daily dose of gliquidone costs, country by country.
Normalised to the WHO defined daily dose (60 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Gliquidone · price per daily dose (60 mg)
USD · FX 28 Sept 2026
- IT Italy$0.28
The record
At a glance
URPL (Poland)- Active substance
- Gliquidonum
- Manufacturer
- InPharm Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- A10BB08
- ATC class
- Gliquidone
- Defined daily dose
- 60 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991323769
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Gliquidone in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaGLURENORMZentiva, k.s., Praha
- United KingdomGlurenorm 30mg tabletsSanofi
- BelgiumGlurenorm 30 mgMenarini Benelux
- GermanyGlurenormGlenwood Gmbh
- ItalyGLURENOR*40 cpr 30 mgLABORATORI GUIDOTTI SpA
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Austria · Glurenorm
- Belgium · Glurenorm
- Czechia · Glurenorm
- Germany · Glurenorm
- Croatia · Glurenorm
- Hungary · Glurenorm
- Italy · Glurenor
- Lithuania · Glurenorm
- Luxembourg · Glurenorm
- Romania · Glurenorm
- Slovenia · Glurenorm
- Slovakia · Glurenorm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/008199ab-9544-411b-bbe5-ba12f7b22441 GET /v1/drugs/008199ab-9544-411b-bbe5-ba12f7b22441?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "30 mg",
"packaging": "05909991323769 ¦ Rp ¦ 121300\n50 tabl.",
"substance": "Gliquidonum 30 mg",
"common_name": "Gliquidonum",
"pl_product_id": "100385698",
"pozwolenie_nr": "114/17",
"auth_procedure": "IR",
"authorisation_validity": "2027-03-31"
}See everything about gliquidone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.